Your browser doesn't support javascript.
loading
The impact of celecoxib on outcomes in advanced prostate cancer patients undergoing androgen deprivation therapy.
Etheridge, Tyler; Liou, Jinning; Downs, Tracy M; Abel, E Jason; Richards, Kyle A; Jarrard, David F.
Afiliación
  • Etheridge T; Department of Urology, University of Wisconsin School of Medicine and Public Health Madison, WI.
  • Liou J; Department of Medicine, University of Wisconsin School of Medicine and Public Health Madison, WI.
  • Downs TM; Department of Urology, University of Wisconsin School of Medicine and Public Health Madison, WI.
  • Abel EJ; Department of Urology, University of Wisconsin School of Medicine and Public Health Madison, WI.
  • Richards KA; Department of Urology, University of Wisconsin School of Medicine and Public Health Madison, WI.
  • Jarrard DF; Department of Urology, University of Wisconsin School of Medicine and Public Health Madison, WI.
Am J Clin Exp Urol ; 6(3): 123-132, 2018.
Article en En | MEDLINE | ID: mdl-30038944
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Tipo de estudio: Prognostic_studies Idioma: En Revista: Am J Clin Exp Urol Año: 2018 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Tipo de estudio: Prognostic_studies Idioma: En Revista: Am J Clin Exp Urol Año: 2018 Tipo del documento: Article